ArrowMark Partners

Founded 2007

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 40
Average round size
info
The average size of a deal this fund participated in
$100M
Portfolio companies 41
Rounds per year 2.86
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 21
Key employees 2
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
Summary

ArrowMark Partners is the famous VC, which was founded in 2007. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Denver.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Moderna Therapeutics, Twilio, Orchard Therapeutics. Among the most successful fund investment fields, there are SMS, Medical. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this ArrowMark Partners performs on 6 percentage points more the average number of lead investments. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2018. The typical startup value when the investment from ArrowMark Partners is more than 1 billion dollars.

We also calculated 2 valuable employees in our database.

The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the ArrowMark Partners, startups are often financed by F-Prime Capital, New Enterprise Associates, Pfizer Venture Investments. The meaningful sponsors for the fund in investment in the same round are Perceptive Advisors, RA Capital Management, OrbiMed. In the next rounds fund is usually obtained by The Durst Organization Inc., Elysium Capital Management, Stratim Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of ArrowMark Partners:
Typical Co-investors
ArrowMark Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after ArrowMark Partners:

Funds with similar focus

Funds from United States, Denver
Funds with similar focus located in United States, Denver:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Frontier Medicines

Artificial Intelligence
Biotechnology
Pharmaceutical
1
$88M19 Jul 2021 California San Francisco United States

Tvardi Therapeutics

Biotechnology
Health Care
Pharmaceutical
1
$72M15 Jun 2021 Houston Texas United States

Latch

Apps
Hardware
Security
Smart Home
Software
n/a
$190M07 Jun 2021 New York United States

Binx Health

Biotechnology
Health Care
Health Diagnostics
Medical Device
Mobile
1
$104M27 May 2021 Boston Massachusetts United States

Adagio Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
1
$336M19 Apr 2021 Massachusetts United States

AbSci

Artificial Intelligence
Biopharma
Biotechnology
Life Science
Machine Learning
n/a
$125M23 Mar 2021 United States Vancouver Washington

Adagio Medical

Health Care
Medical
Pharmaceutical
1
$42M12 Nov 2020 California United States

Shift

Automotive
E-Commerce
Internet
Logistics
Marketplace
Retail Technology
n/a
$185M14 Oct 2020 California San Francisco United States

Xometry

3D Printing
E-Commerce
Industrial Engineering
Manufacturing
Marketplace
Mechanical Engineering
1
$75M09 Sep 2020 Maryland United States
News
SmartLabs Announces $250 Million Series B and Update of Proprietary Laboratory OS

– SmartLabs, a Boston-based Laboratory-as-a-Service (LaaS) leader, announced the raise of a $250m Series B financing.
– The funding round was led by ArrowMark Partners. New investment partners include Winslow Capital Management and Onex Falcon, joined by existing investors Conversion Venture Capital (CVC2) and Breed’s Hill Capital.
– The funding will fuel the company’s accelerated growth, with a plan to scale operations to 2m sq ft within five years.
– In addition, SmartLabs announced the launch of the fourth version of its proprietary laboratory operations system (SmartLabs OS) which was first pioneered and introduced in 2016.

Tvardi Therapeutics Raises $74M in Series B Financing

– Tvardi Therapeutics, Inc. from Houston, Texas is a clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors.
– The company closed a $74m Series B funding.
– The round was led by new investors Slate Path Capital, Palkon Capital, ArrowMark Partners, and 683 Capital with participation from existing investors including Sporos Bioventures.
– The new investment will be aimed at advancing its product candidates through multiple clinical data readouts in mid-stage trials for cancer and fibrosis.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent ArrowMark Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: